[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible). \\nVerdict: Not uniquely determinable. \\nThe patient has obstructive hypertrophic cardiomyopathy (HCM) with severe resting gradient (80 mmHg) and recurrent syncope, refractory to beta-blockers. \\n\\nLogical Issue: Both Septal Myectomy (Option B) and Mavacamten (Option E) are guideline-directed therapies for this scenario. Septal myectomy is the long-standing 'gold standard' (Class I) for drug-refractory severe obstruction, particularly in patients with syncope (a high-risk alarm symptom) who are good surgical candidates. Mavacamten is a newer FDA-approved medical therapy (Class IIa/I depending on update) that can be used as an alternative to surgery. The vignette does not provide information on surgical candidacy (e.g., operative risk) or patient preference, which are the deciding factors between escalating medical therapy (Mavacamten) and proceeding to definitive septal reduction (Myectomy). Furthermore, recurrent syncope is a risk factor for sudden cardiac death, making ICD placement (Option A) a consideration if the syncope is not clearly attributed solely to obstruction, though relief of obstruction is the primary goal here. \\n\\nMinimal Fix: Add 'The patient wishes to avoid invasive procedures' or 'The patient is considered high risk for surgery' to the stem. This would make Option E the unique best answer.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible). \nVerdict: Not uniquely determinable. \nThe patient has obstructive hypertrophic cardiomyopathy (HCM) with severe resting gradient (80 mmHg) and recurrent syncope, refractory to beta-blockers. \n\nLogical Issue: Both Septal Myectomy (Option B) and Mavacamten (Option E) are guideline-directed therapies for this scenario. Septal myectomy is the long-standing 'gold standard' (Class I) for drug-refractory severe obstruction, particularly in patients with syncope (a high-risk alarm symptom) who are good surgical candidates. Mavacamten is a newer FDA-approved medical therapy (Class IIa/I depending on update) that can be used as an alternative to surgery. The vignette does not provide information on surgical candidacy (e.g., operative risk) or patient preference, which are the deciding factors between escalating medical therapy (Mavacamten) and proceeding to definitive septal reduction (Myectomy). Furthermore, recurrent syncope is a risk factor for sudden cardiac death, making ICD placement (Option A) a consideration if the syncope is not clearly attributed solely to obstruction, though relief of obstruction is the primary goal here. \n\nMinimal Fix: Add 'The patient wishes to avoid invasive procedures' or 'The patient is considered high risk for surgery' to the stem. This would make Option E the unique best answer.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. \\nThe clinical vignette describes a patient with a right thalamic hemorrhage. The key discriminating factor is the anatomical location of the bleed. Deep intracerebral hemorrhages (thalamus, basal ganglia, pons) are classically caused by hypertensive vasculopathy (lipohyalinosis/arteriolosclerosis). In contrast, Cerebral Amyloid Angiopathy (Option A) typically affects cortical vessels, resulting in lobar hemorrhages. Option D is incorrect because orthostatic hypotension typically leads to hypoperfusion and watershed infarction (ischemia), not hemorrhage. Options C and E are not recognized mechanisms. \\n\\nLogically, the item is solvable by elimination and anatomical localization. Although the stem mentions \\\"orthostatic hypotension\\\" and omits a history of hypertension, this does not create a contradiction or underspecification. Patients with Parkinson's disease and autonomic failure frequently exhibit \\\"supine hypertension,\\\" which drives the small vessel disease described. The item correctly tests the association between hemorrhage location and etiology, and the distractors are medically implausible for the findings presented. \\n\\nMinimal fix: None required, though adding \\\"and supine hypertension\\\" to the history would reduce potential confusion regarding the risk factor.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. \nThe clinical vignette describes a patient with a right thalamic hemorrhage. The key discriminating factor is the anatomical location of the bleed. Deep intracerebral hemorrhages (thalamus, basal ganglia, pons) are classically caused by hypertensive vasculopathy (lipohyalinosis/arteriolosclerosis). In contrast, Cerebral Amyloid Angiopathy (Option A) typically affects cortical vessels, resulting in lobar hemorrhages. Option D is incorrect because orthostatic hypotension typically leads to hypoperfusion and watershed infarction (ischemia), not hemorrhage. Options C and E are not recognized mechanisms. \n\nLogically, the item is solvable by elimination and anatomical localization. Although the stem mentions \"orthostatic hypotension\" and omits a history of hypertension, this does not create a contradiction or underspecification. Patients with Parkinson's disease and autonomic failure frequently exhibit \"supine hypertension,\" which drives the small vessel disease described. The item correctly tests the association between hemorrhage location and etiology, and the distractors are medically implausible for the findings presented. \n\nMinimal fix: None required, though adding \"and supine hypertension\" to the history would reduce potential confusion regarding the risk factor.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a patient with Type 1 Diabetes, vitiligo, and autoimmune thyroiditis presenting with hypoglycemia, low cortisol, and elevated ACTH. This clinical picture is classic for Polyglandular Autoimmune Syndrome Type 2 (PAS-2), and the labs (low cortisol + high ACTH) are diagnostic of Primary Adrenal Insufficiency (PAI). While a Cosyntropin stimulation test (Option A) is the gold standard to confirm functional adrenal insufficiency, the presence of low morning cortisol with elevated ACTH is already strongly indicative of PAI. The question asks to confirm the 'suspected diagnosis' in a patient with a strong autoimmune diathesis, implying the need to establish the specific etiology (autoimmune adrenalitis). The 21-Hydroxylase antibody assay (Option C) is the specific test to confirm autoimmune adrenalitis. Therefore, C is the best answer as it addresses the etiology suggested by the patient's history, whereas A would be redundant if cortisol is unequivocally low and does not distinguish etiology. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a patient with Type 1 Diabetes, vitiligo, and autoimmune thyroiditis presenting with hypoglycemia, low cortisol, and elevated ACTH. This clinical picture is classic for Polyglandular Autoimmune Syndrome Type 2 (PAS-2), and the labs (low cortisol + high ACTH) are diagnostic of Primary Adrenal Insufficiency (PAI). While a Cosyntropin stimulation test (Option A) is the gold standard to confirm functional adrenal insufficiency, the presence of low morning cortisol with elevated ACTH is already strongly indicative of PAI. The question asks to confirm the 'suspected diagnosis' in a patient with a strong autoimmune diathesis, implying the need to establish the specific etiology (autoimmune adrenalitis). The 21-Hydroxylase antibody assay (Option C) is the specific test to confirm autoimmune adrenalitis. Therefore, C is the best answer as it addresses the etiology suggested by the patient's history, whereas A would be redundant if cortisol is unequivocally low and does not distinguish etiology. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Miskeyed (K). Verdict: The provided key (B) is incorrect based on the vignette findings. The stem explicitly describes 'mediastinal lymphadenopathy' in a patient with a 2 cm lung nodule. In lung cancer staging, ipsilateral mediastinal lymphadenopathy implies N2 disease (Stage IIIA), not Stage I. The standard of care for Stage IIIA (N2) disease is typically concurrent chemoradiotherapy (Option C) or induction therapy followed by re-evaluation, rather than upfront surgical lobectomy. The author's explanation incorrectly classifies this as 'Stage I,' ignoring the stated lymphadenopathy. Additionally, the patient has COPD with 'progressive dyspnea,' but no pulmonary function tests (PFTs) are provided; if the patient has severe functional impairment, they would be medically inoperable, making SBRT (Option A) the correct choice. As written, the presence of mediastinal nodes makes Option C the most appropriate management among the choices, while the key (B) is contraindicated or at least not the standard initial step. Minimal fix: Change 'mediastinal lymphadenopathy' to 'no mediastinal lymphadenopathy' and add 'adequate pulmonary function' to confirm operability.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Miskeyed (K). Verdict: The provided key (B) is incorrect based on the vignette findings. The stem explicitly describes 'mediastinal lymphadenopathy' in a patient with a 2 cm lung nodule. In lung cancer staging, ipsilateral mediastinal lymphadenopathy implies N2 disease (Stage IIIA), not Stage I. The standard of care for Stage IIIA (N2) disease is typically concurrent chemoradiotherapy (Option C) or induction therapy followed by re-evaluation, rather than upfront surgical lobectomy. The author's explanation incorrectly classifies this as 'Stage I,' ignoring the stated lymphadenopathy. Additionally, the patient has COPD with 'progressive dyspnea,' but no pulmonary function tests (PFTs) are provided; if the patient has severe functional impairment, they would be medically inoperable, making SBRT (Option A) the correct choice. As written, the presence of mediastinal nodes makes Option C the most appropriate management among the choices, while the key (B) is contraindicated or at least not the standard initial step. Minimal fix: Change 'mediastinal lymphadenopathy' to 'no mediastinal lymphadenopathy' and add 'adequate pulmonary function' to confirm operability.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). \\nVerdict: Keyed answer (E) is defensible as the best option in this specific niche scenario. \\n\\nThe clinical vignette describes a cocaine-induced STEMI with angiography confirming thrombus but explicitly noting 'no underlying atherosclerosis.' This is the critical discriminator. \\n\\n1.  **Stenting (B)** is generally contraindicated or avoided in vessels without atherosclerotic plaque (e.g., spasm or pure thrombus) to avoid permanent implants in healthy vessels.\\n2.  **Thrombolysis (A)** is inappropriate as the patient is already in the catheterization laboratory.\\n3.  **Heparin (C)** and **GP IIb/IIIa inhibitors (D)** are standard adjunctive pharmacotherapies, but they do not provide immediate mechanical reperfusion for an occlusive thrombus causing STEMI.\\n4.  **Aspiration thrombectomy (E)**, while downgraded in guidelines for *routine* use in atherosclerotic STEMI (TOTAL/TASTE trials), remains a preferred strategy for 'bailout' or specific scenarios like large thrombus burden in non-atherosclerotic vessels (e.g., embolism, cocaine-induced) to restore flow without stenting.\\n\\nThus, E is the only option that addresses the mechanical obstruction appropriately given the contraindication to stenting.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). \nVerdict: Keyed answer (E) is defensible as the best option in this specific niche scenario. \n\nThe clinical vignette describes a cocaine-induced STEMI with angiography confirming thrombus but explicitly noting 'no underlying atherosclerosis.' This is the critical discriminator. \n\n1.  **Stenting (B)** is generally contraindicated or avoided in vessels without atherosclerotic plaque (e.g., spasm or pure thrombus) to avoid permanent implants in healthy vessels.\n2.  **Thrombolysis (A)** is inappropriate as the patient is already in the catheterization laboratory.\n3.  **Heparin (C)** and **GP IIb/IIIa inhibitors (D)** are standard adjunctive pharmacotherapies, but they do not provide immediate mechanical reperfusion for an occlusive thrombus causing STEMI.\n4.  **Aspiration thrombectomy (E)**, while downgraded in guidelines for *routine* use in atherosclerotic STEMI (TOTAL/TASTE trials), remains a preferred strategy for 'bailout' or specific scenarios like large thrombus burden in non-atherosclerotic vessels (e.g., embolism, cocaine-induced) to restore flow without stenting.\n\nThus, E is the only option that addresses the mechanical obstruction appropriately given the contraindication to stenting.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is logically invalid because it is underspecified regarding the type of anticoagulant. The stem states the patient is 'on anticoagulation' but does not distinguish between a Vitamin K Antagonist (e.g., warfarin) and a Direct Oral Anticoagulant (DOAC). If the patient is on warfarin, Option A (INR) is the correct determinant, as IVT is contraindicated if INR > 1.7. However, if the patient is on a DOAC (now the standard of care for most non-valvular atrial fibrillation), INR is insensitive and unreliable; eligibility is primarily determined by the time since the last dose (Option B), typically requiring >48 hours or specific normal assays (anti-Xa/TT). Without specifying the drug, it is impossible to choose between A and B. The rationale admits the author assumed warfarin ('in patients on vitamin K antagonists'), but this constraint is absent from the stem. To fix, the stem must explicitly state 'on warfarin'.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically invalid because it is underspecified regarding the type of anticoagulant. The stem states the patient is 'on anticoagulation' but does not distinguish between a Vitamin K Antagonist (e.g., warfarin) and a Direct Oral Anticoagulant (DOAC). If the patient is on warfarin, Option A (INR) is the correct determinant, as IVT is contraindicated if INR > 1.7. However, if the patient is on a DOAC (now the standard of care for most non-valvular atrial fibrillation), INR is insensitive and unreliable; eligibility is primarily determined by the time since the last dose (Option B), typically requiring >48 hours or specific normal assays (anti-Xa/TT). Without specifying the drug, it is impossible to choose between A and B. The rationale admits the author assumed warfarin ('in patients on vitamin K antagonists'), but this constraint is absent from the stem. To fix, the stem must explicitly state 'on warfarin'.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of central diabetes insipidus (CDI) following transsphenoidal pituitary surgery, evidenced by significant polyuria (>300 mL/hr), hypernatremia (148 mEq/L), and maximally dilute urine (SG 1.002). The mechanism is a deficiency of ADH due to posterior pituitary/stalk injury. Desmopressin (DDAVP) is the standard pharmacologic intervention to replace ADH, concentrate urine, and prevent free water loss. The distractors are well-chosen but incorrect: Hydrochlorothiazide is indicated for nephrogenic DI (not central); Demeclocycline, Tolvaptan, and Conivaptan are used for SIADH (hyponatremia/fluid overload) and would be contraindicated here as they would worsen the hypernatremia and volume depletion. The item is medically accurate, logically sound, and supports a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of central diabetes insipidus (CDI) following transsphenoidal pituitary surgery, evidenced by significant polyuria (>300 mL/hr), hypernatremia (148 mEq/L), and maximally dilute urine (SG 1.002). The mechanism is a deficiency of ADH due to posterior pituitary/stalk injury. Desmopressin (DDAVP) is the standard pharmacologic intervention to replace ADH, concentrate urine, and prevent free water loss. The distractors are well-chosen but incorrect: Hydrochlorothiazide is indicated for nephrogenic DI (not central); Demeclocycline, Tolvaptan, and Conivaptan are used for SIADH (hyponatremia/fluid overload) and would be contraindicated here as they would worsen the hypernatremia and volume depletion. The item is medically accurate, logically sound, and supports a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. The vignette clearly describes an Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF), evidenced by acute worsening dyspnea, new ground-glass opacities superimposed on fibrosis, and the exclusion of infection via BAL. The keyed answer, high-dose systemic corticosteroids (A), aligns with international guidelines (ATS/ERS/JRS/ALAT) which suggest corticosteroids as the standard first-line intervention for AE-IPF, despite the evidence being conditional. The distractors are effectively ruled out: Azathioprine (B) is contraindicated in IPF due to increased mortality (PANTHER-IPF trial); Pirfenidone (C) and Nintedanib (D) are maintenance antifibrotics not indicated for acute rescue; and Lung Transplantation evaluation (E) is a long-term management step, not the immediate therapeutic action for the acute crisis. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. The vignette clearly describes an Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF), evidenced by acute worsening dyspnea, new ground-glass opacities superimposed on fibrosis, and the exclusion of infection via BAL. The keyed answer, high-dose systemic corticosteroids (A), aligns with international guidelines (ATS/ERS/JRS/ALAT) which suggest corticosteroids as the standard first-line intervention for AE-IPF, despite the evidence being conditional. The distractors are effectively ruled out: Azathioprine (B) is contraindicated in IPF due to increased mortality (PANTHER-IPF trial); Pirfenidone (C) and Nintedanib (D) are maintenance antifibrotics not indicated for acute rescue; and Lung Transplantation evaluation (E) is a long-term management step, not the immediate therapeutic action for the acute crisis. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic trauma scenario: a hemodynamically unstable patient with a positive FAST exam who has already been taken to the operating room for exploratory laparotomy. The intraoperative finding is a splenic laceration. In the context of hemodynamic instability, the primary surgical goal is rapid control of hemorrhage (damage control principles). Total splenectomy (Option D) is the standard of care in this situation because it is the fastest and most reliable method to stop bleeding. Spleen-preserving techniques like partial splenectomy (Option B) or splenorrhaphy (Option C) are time-consuming and generally reserved for hemodynamically stable patients. Splenic artery embolization (Option A) and non-operative management (Option E) are inappropriate because the patient is unstable and already undergoing laparotomy; these are strategies for stable patients or those who respond to resuscitation without needing immediate open surgery. The item is medically accurate, logically sound, and the distractors are well-defined based on hemodynamic status.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic trauma scenario: a hemodynamically unstable patient with a positive FAST exam who has already been taken to the operating room for exploratory laparotomy. The intraoperative finding is a splenic laceration. In the context of hemodynamic instability, the primary surgical goal is rapid control of hemorrhage (damage control principles). Total splenectomy (Option D) is the standard of care in this situation because it is the fastest and most reliable method to stop bleeding. Spleen-preserving techniques like partial splenectomy (Option B) or splenorrhaphy (Option C) are time-consuming and generally reserved for hemodynamically stable patients. Splenic artery embolization (Option A) and non-operative management (Option E) are inappropriate because the patient is unstable and already undergoing laparotomy; these are strategies for stable patients or those who respond to resuscitation without needing immediate open surgery. The item is medically accurate, logically sound, and the distractors are well-defined based on hemodynamic status.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict on keyed answer: Correct best. The patient presents with symptomatic severe primary mitral regurgitation (MR) due to a flail leaflet. According to ACC/AHA guidelines, the Class I recommendation for symptomatic severe primary MR is surgical intervention. Mitral valve repair (Option A) is strongly preferred over replacement (Option B) whenever the valve is anatomically suitable for repair, as it preserves LV function and avoids prosthesis-related complications. A flail leaflet is a classic pathology highly amenable to repair. Transcatheter edge-to-edge repair (Option C) is indicated for primary MR only in patients at high or prohibitive surgical risk. While the patient has rheumatoid arthritis, the stem does not provide evidence of high surgical risk (e.g., frailty, severe lung disease) that would preclude surgery; thus, surgical repair remains the standard of care over TEER. Medical management (Option D) is not a definitive treatment for symptomatic severe primary MR. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict on keyed answer: Correct best. The patient presents with symptomatic severe primary mitral regurgitation (MR) due to a flail leaflet. According to ACC/AHA guidelines, the Class I recommendation for symptomatic severe primary MR is surgical intervention. Mitral valve repair (Option A) is strongly preferred over replacement (Option B) whenever the valve is anatomically suitable for repair, as it preserves LV function and avoids prosthesis-related complications. A flail leaflet is a classic pathology highly amenable to repair. Transcatheter edge-to-edge repair (Option C) is indicated for primary MR only in patients at high or prohibitive surgical risk. While the patient has rheumatoid arthritis, the stem does not provide evidence of high surgical risk (e.g., frailty, severe lung disease) that would preclude surgery; thus, surgical repair remains the standard of care over TEER. Medical management (Option D) is not a definitive treatment for symptomatic severe primary MR. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]